SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950103-15-000449
Filing Date
2015-01-21
Accepted
2015-01-21 16:42:34
Documents
5
Group Members
ROCHE FINANCE LTDROCHE HOLDINGS, INC.

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D dp52722_sc13d.htm SC 13D 242865
2 EXHIBIT 99.1 dp52722_ex9901.htm EX-99.1 13942
3 EXHIBIT 99.2 dp52722_ex9902.htm EX-99.2 119338
4 EXHIBIT 99.3 dp52722_ex9903.htm EX-99.3 122284
5 EXHIBIT 99.4 dp52722_ex9904.htm EX-99.4 113050
  Complete submission text file 0000950103-15-000449.txt   613070
Mailing Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070
Business Address ROCHE HOLDING, LTD. GRENZACHERSTRASSE 124 BASEL V8 CH-4070 9732354295
ROCHE HOLDING LTD (Filed by) CIK: 0000889131 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8
Type: SC 13D
SIC: 8880 American Depositary Receipts

Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Subject) CIK: 0001488613 (see all company filings)

IRS No.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87922 | Film No.: 15538998
SIC: 8071 Services-Medical Laboratories